Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Bacterial Infection
Study Phase
Phase 3
Study Completion Date
2019-03-31
NCT01817075Uploaded 06-19-2021
Access via NCI by Request
PDS UID: nci-data-473
Impact of Cleansing With Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLABSI) and Acquisition of Multi-drug Resistant Organisms (MDRO) in Children With Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplantation (HCT)
Provider Information
Provider Data DescriptionNCT01817075-D1: There are 5 datasets associated with PMID 33079403. This dataset, NCT01817075-D1, provides the information for the consort diagram in the manuscript (Figure 1). Data provided for all enrolled patients (N=177). There is one row per patient.
SponsorChildren's Oncology Group
Data ProviderNational Cancer Institute
Clinical Trials.gov Information
Brief SummaryThis randomized phase III trial studies chlorhexidine gluconate cleansing to see how well it works compared to control cleansing in preventing central line associated bloodstream infection and acquisition of multi-drug resistant organisms in younger patients with cancer or undergoing donor stem cell transplant. Chlorhexidine gluconate may help reduce bloodstream infections and bacterial infections associated with the central line.
ConditionsBacterial Infection
Benign Neoplasm
Malignant Neoplasm
Methicillin-Resistant Staphylococcus Aureus Infection
Myeloid Neoplasm
Recurrent Childhood Acute Lymphoblastic Leukemia
Recurrent Childhood Acute Myeloid Leukemia
Intervention TypeProcedure: Chlorhexidine Gluconate Skin Cleanser
Other: Laboratory Biomarker Analysis
Procedure: Mild Soap Skin Cleanser
Other: Questionnaire Administration
Drug(s)N/A
Total Enrolled177
RandomizationRandomized
Blinding MethodDouble
Arms InterventionArm I (CHG cleansing wipe) - Experimental
Arm II (control) - Active Comparator
Secondary IDNCI-2013-00595
PubMed (PMID)N/A
Collaborator(s)National Cancer Institute (NCI)
Region(s)United States
Canada
Puerto Rico
Age Range2 Months to 21 Years (CHILD, ADULT)
Files: NCT01817075-D1
Data DictionaryNCT01817075-D1-Data-Dictionary.pdf
DATANCT01817075-D1-Dataset.CSV
OTHERREADME.pdf
Files: NCT01817075-D2
Data DictionaryNCT01817075-D2-Data-Dictionary_1.pdf
DATANCT01817075-D2-Dataset_1.CSV
OTHERREADME.pdf
Files: NCT01817075-D3
Data DictionaryNCT01817075-D3-Data-Dictionary.pdf
DATANCT01817075-D3-Dataset.CSV
OTHERREADME.pdf
Files: NCT01817075-D4
Data DictionaryNCT01817075-D4-Data-Dictionary_1.pdf
DATANCT01817075-D4-Dataset_1.CSV
OTHERREADME.pdf
Files: NCT01817075-D5
Data DictionaryNCT01817075-D5-Data-Dictionary.pdf
DATANCT01817075-D5-Dataset.CSV
OTHERREADME.pdf
© 2024 Project Data Sphere
All rights reserved
Privacy PolicyTerms of Use